ABLE: Phase 2, single-arm, two-stage study of nabpaclitaxel with anti-PD1/PDL1 in advanced urothelial cancer von Tsung, Irene, Green, Edward, Palmbos, Phillip Lee, Reichert, Zachery R, Vaishampayan, Ulka N., Smith, David C., Caram, Megan Veresh, Yentz, Sarah Elizabeth, Daignault-Newton, Stephanie, Sloan, Zachery, Hurley, Laura, Alva, Ajjai Shivaram

Volltext